Charles Flexner

14.4k citations
185 papers · 10.8k · 3 hit papers · h-index 51

Impact in

  • Virology top 0.05%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 89
    • HIV/AIDS Research and Interventions 41
    • HIV Research and Treatment 68

Charles Flexner

180 papers receiving 10.5k citations

Charles Flexner's Hit Papers

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications 2022 · 170 citations
1700+9+18Years since publication50010001.5k

Peers

Charles Flexner
Comparison fields: 5 of 147
  • Virology 4.6k
  • Infectious Diseases 4.8k
  • Emergency Medicine 737
  • Immunology 1.7k
  • Epidemiology 1.9k
Replace Craig W. Hendrix with:
Craig W. Hendrix United States
Courtney V. Fletcher United States
Paul Deutsch United States
Daria J. Hazuda United States
Carlo Federico Perno Italy
Joseph A. Kovacs United States
Roger J. Pomerantz United States
Ann C. Collier United States
Oscar L. Laskin United States
Roy M. Gulick United States
Charles Flexner relative to Craig W. Hendrix United States Craig W. Hendrix's profile →
Citations per field
00.5×1.5×2.2×
Craig W. Hendrix · 1×
Citations per year

Countries citing papers authored by Charles Flexner

Since Specialization
Citations

This map shows the geographic impact of Charles Flexner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Flexner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Flexner more than expected).

Fields of papers citing papers by Charles Flexner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Flexner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Flexner. The network helps show where Charles Flexner may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles Flexner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Flexner Line = papers co-authored together Charles Flexner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Hit paper breakdown →
19991647
2
HIV-Protease Inhibitors
Hit paper breakdown →
1998676
3 2000406
4 1994318
5 2004285
6 2007236
7 1988230
8 1987219
9 1996211
10 1989205
11 2001204
12 2007197
13 2000182
14 1987181
15 2009180
16
Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
Hit paper breakdown →
2022170
17 1998160
18 2012145
19 2007131
20 1991122

About Charles Flexner

Charles Flexner is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Molecular Biology, having authored 185 papers that have together received 10.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (89 papers), HIV Research and Treatment (68 papers), HIV/AIDS Research and Interventions (41 papers), HIV-related health complications and treatments (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers), Immune Cell Function and Interaction (14 papers), Herpesvirus Infections and Treatments (8 papers) and Hepatitis C virus research (8 papers). The work is most often cited by research in Virology (4.6k citations), Infectious Diseases (4.8k citations), Emergency Medicine (737 citations), Immunology (1.7k citations) and Epidemiology (1.9k citations). Charles Flexner has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Bernard Moss, Bruce D. Walker, Richard E. Chaisson, Robert F. Siliciano, Joel E. Gallant, Roy M. Gulick, Kendall A. Smith, Franco Lori, Joseph B. Margolick and Eric Rosenberg. Their work appears in journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact